Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

MB-CART19.1

Grade I immune-effector cell associated neurotoxicity syndrome

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mueller F, et al. CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients. Blood 142 (Suppl. 1): Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-180547 [abstract] Mueller F, et al. CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients. Blood 142 (Suppl. 1): Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2023-180547 [abstract]
Metadaten
Titel
MB-CART19.1
Grade I immune-effector cell associated neurotoxicity syndrome
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58281-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Tozinameran

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Pembrolizumab

Case report

Lorazepam